Joan Admirand, M.D.


Joined Clinical Pathology Associates:  2007

Primary Service Location:

Dell Seton Medical Center at the University of Texas

Medical Directorships:

  • Dell Seton Medical Center at the University of Texas

Board Certifications:

  • Anatomic and Clinical Pathology (2002)
  • Hematopathology (2006)


  • Surgical Pathology, University of Iowa School of Medicine
  • Hematopathology, University of Texas M.D. Anderson Cancer Center


  • University of Utah School of Medicine (AP/CP)

Medical School:

  • Wake Forest University Bowman Gray School of Medicine

Undergraduate Education:

  • Middlebury College

Additional Education:

  • University of Nevada School of Medicine – Master of Science: Cell and Molecular Biology


  • T-cell receptor signaling in peripheral T-cell lymphoma – a review of patterns of alterations in a central growth regulatory pathway.Warner K, Weit N, Crispatzu G, Admirand J, Jones D, Herling M.  Curr Hematol Malig Rep. 2013 Sep;8(3):163-72.
  • Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression. Admirand JH, Knoblock RJ, Coombes KR, Tam C, Schlette EJ, Wierda WG, Ferrajoli A, O’Brien S, Keating MJ, Luthra R, Medeiros LJ, Abruzzo LV.  Mod Pathol. 2010 Nov;23(11):1518-23.
  • p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy.Schlette EJ, Admirand J, Wierda W, Abruzzo L, Lin KI, O’Brien S, Lerner S, Keating MJ, Tam C.  Leuk Lymphoma. 2009 Oct;50(10):1597-605.
  • Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia.Khouri IF, Saliba RM, Admirand J, O’Brien S, Lee MS, Korbling M, Samuels BI, Giralt S, Lima de M, Keating MJ, Champlin RE, Bueso-Ramos C.  Br J Haematol. 2007 May;137(4):355-63.
  • Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.Admirand JH, Rassidakis GZ, Abruzzo LV, Valbuena JR, Jones D, Medeiros LJ.  Mod Pathol. 2004 Aug;17(8):954-61.